NCT07099599 Image Detection of Impaired Microcirculatory Reperfusion
| NCT ID | NCT07099599 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Cincinnati |
| Condition | Ischemic Stroke, Acute |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-09-30 |
| Primary Completion | 2026-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2024-09-30 with a primary completion date of 2026-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Stroke affects one patient every 40 seconds in the United States. It is most commonly caused by blood clots that develop in the blood vessels of the brain. These blood clots interrupt the normal flow of blood and oxygen to the nerve cells in the brain. When this occurs, the nerve cells can die, causing permanent damage to that area of the brain. That damage can result in loss of normal function to a patient's vision, strength, sensation, balance, or speech. These changes can remain permanent if blood flow is not restored to the brain. Thankfully, there are treatments available to help get rid of these blood clots. One of these treatments is a procedure to physically remove the blood clot causing stroke. This practice is now routinely done at all major stroke centers. Special imaging for stroke is now available at these major stroke centers. This imaging looks at blood flow in and around the area of brain that is dying. By performing these scans after the procedure, we can see that not all of brain is being saved by the procedure. That is a problem, because we know that saving brain cells can make a big difference in how patients recover from stroke. The purpose of this study is to determine which brain tissue will not get saved by blood clot removal. We will do this by using specialized imaging after the procedure. The study will discover if there is more brain tissue that can be saved after the procedure. Once we can determine this, our next steps will be looking at ways to save this tissue in the studies that follow. For example, we will look to see if medications can be given after the procedure to help save those brain areas. This study lays the groundwork for future studies to help save all the brain tissue we possibly can from dying during the stroke. This is our best chance of getting all patients affected by stroke the opportunity to live their best lives after stroke.
Eligibility Criteria
Inclusion Criteria: * Adults greater than or equal to 18 years of age * Last known normal (LKN) within 24 hours * Ischemic stroke due to anterior circulation LVO (intracranial internal carotid artery \[ICA\], proximal middle cerebral artery \[M1\], M1/M2 bifurcation, or proximal dominant M2 occlusion) * mTICI2c or mTICI3 on digital subtracted angiography (DSA) following mechanical thrombectomy Exclusion Criteria: * Significant renal insufficiency (glomerular filtration rate \<30mg/ml/min2 while not on dialysis) * Contraindication to iodinated contrast * Contraindication to magnetic resonance imaging (e.g., pacemaker incompatibility) * Prior significant stroke in same vascular territory ipsilateral stroke * Tandem vessel occlusion (i.e., extracranial ICA and ipsilateral intracranial M1/M2 occlusion) * Greater than 4 clot retrieval attempts * Enrollment in another acute stroke interventional study (with the exception of thrombectomy device registries) * Pregnancy * Prisoners
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07099599 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ischemic Stroke, Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07099599 currently recruiting?
Yes, NCT07099599 is actively recruiting participants. Contact the research team at azizyn@ucmail.uc.edu for enrollment information.
Where is the NCT07099599 trial being conducted?
This trial is being conducted at Cincinnati, United States.
Who is sponsoring the NCT07099599 clinical trial?
NCT07099599 is sponsored by University of Cincinnati. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.